Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials. uri icon

authors

  • Silverberg, Jonathan I
  • Vakil, Jignesh
  • Marco, Ainara Rodríguez
  • Levit, Noah A
  • Lynde, Charles W
  • Katrina Abuabara, MD, MA, MSCE
  • Patruno, Cataldo
  • de Benedetto, Anna
  • Zhang, Haixin
  • Thomas, Ryan B
  • Bégo-Le-Bagousse, Gaëlle
  • Khokhar, Faisal A

publication date

  • January 1, 2023